Evidence map›Paper›PMID 41700166›Full record

ArticleWorld journal of gastrointestinal endoscopy2026

Bowel preparation for small bowel capsule endoscopy in patients with suspected or established Crohn's disease.

Shohei Terashi, Sotaro Ozaka, Yomei Kagoshima, Yuta Shimomori, Haruhiko Takahashi, Daisuke Minezaki, Koshiro Tsutsumi, Masahide Fukuda, Yuka Hirashita, Kensuke Fukuda and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shohei TerashiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Sotaro OzakaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Yomei KagoshimaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Yuta ShimomoriDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Haruhiko TakahashiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Daisuke MinezakiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Koshiro TsutsumiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Masahide FukudaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Yuka HirashitaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Kensuke FukudaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Ryo OgawaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Masaaki KodamaDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Kazunari MurakamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.
Kazuhiro MizukamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, Yufu 879-5593, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough small-bowel capsule endoscopy (SBCE) is an important tool in the diagnosis of Crohn's disease (CD), the necessity and consensus protocol of preprocedural bowel pre-treatment for SBCE in patients with CD have not yet been established.

aimTo evaluate the diagnostic performance and mucosal visibility of SBCE with and without bowel preparation in patients with CD.

methodsPatients with suspected or established CD who underwent SBCE at our hospital between January 2015 and March 2025 were included in this retrospective observational study. SBCE was performed after bowel preparation with fasting only or with 1 L of polyethylene glycol solution with liquid simethicone. The primary outcome was the lesion detection rate. Secondary outcomes were the completion rate of the examination, image quality, gastric transit time, small bowel transit time, and adverse events related to SBCE.

resultsFifty-seven patients were included in the study. The detection rates of lesions were 95.6% in the non-preparation group and 96.6% in the preparation group, with no significant differences between the two groups. The two groups showed no significant differences in completion rates, gastric transit time, small bowel transit time, or visibility score. One patient in the preparation group experienced intestinal obstruction.

conclusionThe diagnostic performance and mucosal visibility of SBCE for CD were not significantly improved by pre-procedural bowel preparation.

Indexed as

Bowel preparationCapsule endoscopyCrohn’s diseaseSmall intestineVisibility

Identifiers

PMID41700166
PMCPMC12906220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.